(WASHINGTON, D.C.) December 15, 2017 – First Line Technology, a leading provider of disaster preparedness and emergency response equipment, today announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.
First Line Technology is recognized for its Dahglren Decon and FiberTect products, which are high efficacy decontamination technologies that can decontaminate chemical warfare agents, toxic industrial chemicals, toxic industrial materials, as well as biological and radiological agents from personnel, personal protective equipment (PPE), sensitive equipment, and critical infrastructure.
As a recipient of the $8.2 billion, multi-vendor contract, First Line Technology has been named a qualified contractor by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). First Line Technology can now compete for JE-RDAP task orders specific to future research, development, production, and fielding of CBRN defense systems.
“Being a qualified recipient of the JE-RDAP contract presents many exciting opportunities for First Line Technology,” said Amit Kapoor, President of First Line Technology. “It allows our lab to life-saving technologies to have greater impact in the evolving CBRN environment and better support those who protect our freedoms every day.”
For more information on First Line Technology please contact firstname.lastname@example.org or call 703-955-7510.
About First Line Technology: First Line Technology, LLC designs and manufactures disaster preparedness and response equipment, including PhaseCore personal cooling items, DeconTect decontamination products, and AmbuResponse mass casualty response systems. Our mission is to prepare for, protect against, respond to and recover from all hazards with lab to life-saving technology. For more information, visit www.firstlinetech.com.